NCT05146232

Brief Summary

Obesity and pneumoperitoneum in the reverse-Trendelenburg position during laparoscopic sleeve gastrectomy (LSG) are reported to negatively affect cerebral oxygenation. Anesthetic agents can have variable effects on the regional cerebral tissue oxygen saturation (rSO2) measured with near-infrared spectroscopy. This study investigated the potential impact of opioid free versus opioid based anesthesia on rSO2 in LSG cases. 80 American Society of Anesthesiologists (ASA) II-III patients, 18-65 years of age, with a body mass index of \>35 kg/m2 , undergoing LSG were randomized to two groups: opioid free and opioid based groups for anesthesia maintenance. The rSO2 values were recorded preoperatively, 1 min after anesthesia induction, and every 5 min during surgery. Arterial blood gases (ABG) were measured in the fifth minute postinduction (t1), 30th minute postinsuflation (t2), and postextubation (t3), and correlation with rSO2 .

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2022

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 6, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 6, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

February 5, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2022

Completed
Last Updated

February 1, 2022

Status Verified

December 1, 2021

Enrollment Period

2 months

First QC Date

November 6, 2021

Last Update Submit

January 31, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes of regional cerebral oxygen saturation percentage

    Measred noninvasively by electrodes of Masimo oximeter on all patient' forehead before induction of anesthesia

    Measured preoperatively, 1 minute after the induction, and every 5 minutes until the patient will be referred to the recovery unit.

Study Arms (2)

Opioid free group

ACTIVE COMPARATOR

After induction of aesthesia, anesthesia maintained by sevoflurane and continuous unfusion of lidocaine, ketamine, dexmeditomedine and Paracetamol.

Other: induction of anesthesiaOther: maintainance of anesthesiaOther: monitoringOther: First postoperative analgesiaOther: Second postoperative analgesia

Opioid based group

ACTIVE COMPARATOR

After induction of aesthesia, anesthesia maintained by continuous remifentanyl infusion

Other: induction of anesthesiaOther: maintainance of anesthesiaOther: monitoringOther: First postoperative analgesiaOther: Second postoperative analgesia

Interventions

induction of anesthesia during gastric sleeve surgery

Opioid based groupOpioid free group

maintainance of anesthesia during gastric sleeve surgery either opioid free or opioid based

Opioid based groupOpioid free group

electrocardiogram, noninvasive blood pressure, SpO2, rSO2 (Masimo oximeter), and neuromuscular monitoring (TOF-Watch SX; Organon, Dublin, Ireland) were performed on the patients.

Opioid based groupOpioid free group

IV acetaminophen will be administered every 6 h

Opioid based groupOpioid free group

50 mg IV dexketoprofen every 8 h for the first 48 h.

Opioid based groupOpioid free group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASAphysical status class II-III
  • Patients undergoing laparoscopic sleeve

You may not qualify if:

  • neurolgical diseases
  • cardiovascular diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The anesthesiologist caring for the patient will be aware of the group assignments.While the person who is responsible for patient monitor recording and the patients will be blinded to the group assignments.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: The rSO2 values will be recorded preoperatively, 1 min after anesthesia induction, and every 5 min during surgery. Arterial blood gases (ABG) will be measured in the fifth minute postinduction (t1), 30th minute postinsufflation (t2), and postextubation (t3), and correlation with rSO2 will be examined.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

November 6, 2021

First Posted

December 6, 2021

Study Start

February 5, 2022

Primary Completion

March 30, 2022

Study Completion

March 30, 2022

Last Updated

February 1, 2022

Record last verified: 2021-12